Loading...
Derniers dépôts
-
-
-
-
-
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, et al.. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. EMBO Molecular Medicine, 2024, 16 (4), pp.927 - 944. ⟨10.1038/s44321-024-00031-3⟩. ⟨hal-04603972⟩
-
-
-
Julia Pereira Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, Gillian Butler-Browne, Daniella Arêas Mendes-Da-Cruz, et al.. T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. Frontiers in Immunology, 2023, 14, pp.120283. ⟨10.3389/fimmu.2023.1202834⟩. ⟨hal-04603915⟩
-
-
-
-
Angelos Gerassimopoulos, Céline Michaud, Mélanie Gaillet, Cyril Rousseau, Adriana Gonzalez, et al.. Santé et recours aux soins et à la prévention des travailleuses du sexe dominicaines vivant le long du fleuve Maroni. 6e journées des travaux scientifiques des soignant.e.s de Guyane, May 2023, Cayenne, Guyane française. ⟨hal-04585175⟩
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Vanessa Ueberschlag-Pitiot, Amalia Stantzou, Julien Messéant, Megane Lemaitre, Daniel Owens, et al.. Gonad-related factors promote muscle performance gain during postnatal development in male and female mice. AJP - Endocrinology and Metabolism, 2017, 313 (1), pp.E12-E25. ⟨10.1152/ajpendo.00446.2016⟩. ⟨hal-03677800⟩
-
-
-
Hubert Smeets, Bram Verbrugge, Xavier Bulbena, Liliya Hristova, Julia Vogt, et al.. European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain. LAMA2-muscular dystrophy: paving the road to therapy, Neuromuscular Disorders, 36, pp.16 - 22, 2024, ⟨10.1016/j.nmd.2024.01.001⟩. ⟨hal-04546346⟩
-
Nombre de documents
790
Nombre de notices
1 380
widget_cloud
AAV
Long read sequencing
LMNA
Errance diagnostique
Biomarkers
CMS
FSHD
Autoimmunity
Outcome measures
Thérapie génique
Alternative splicing
Heart
Motoneuron
Rare neuromuscular diseases
ALS
Myotonic dystrophy type 1
Mouse model
Brain
Dynamin 2
Laminopathy
Dystrophin
Inflammation
Fibrosis
Satellite cells
Neuromuscular disease
PABPN1
Calcium
Laminopathie
RNA interference
Gene therapy
Congenital myopathy
Transgenic mouse model
Skeletal muscle
Glutamate
Myopathies
Lamin A/C LMNA gene
Autoantibodies
Treatment
OPMD
Antisense oligonucleotides
CTG repeat contractions
Autophagy
Aging
Biomarker
Muscle
Myopathy
CRISPRi
Myotonic Dystrophy type 1
Satellite cell
Thymus
Neuromuscular diseases
Nuclear envelope
Regeneration
Clinical trials
Muscle regeneration
Cancer
Humans
Myotonic Dystrophy
Myoblasts
Cell therapy
Rare diseases
MBNL
Dermatomyositis
Centronuclear myopathy
LMNA gene
Myositis
Astrocyte
Fabry disease
Transcriptomics
Duchenne muscular dystrophy
Becker muscular dystrophy
Exercise
Myasthenia gravis
COVID-19
Cytokines
DMD
Autoimmune diseases
Myotonic dystrophy
Muscular dystrophy
Myogenesis
Mechanotransduction
Cardiomyopathy
Aged
Congenital muscular dystrophy
Genotype phenotype correlation
Dilated cardiomyopathy
Diagnosis
Myasthenia Gravis MG
Amyotrophic lateral sclerosis
Cytoskeleton
RNA biology
Laminopathies
Lamin A/C
Trinucleotide repeat expansion
Therapy
Neuromuscular junction
Male
Animals
Heart failure
Actin